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I. INTRODUCTION
"New technologies challenge societal values, and values influ-
ence the direction of technological development."' Biotechnology2
promises to yield an infinite number of medical choices, improve-
ments, and developments especially with respect to reproduction.
Technological intervention in this area is not limited just to the crea-
tion or prevention of offspring, but also applies to the manipulation
of traits to control resulting characteristics.
In the newly emerging field of reproductive technologies, where
medical prowess is pushed to its limits, dynamic issues and concerns
are quick to rise to the forefront. This paper will argue for the in-
creasing need for federal government intervention in providing a
framework to guide the involved parties in the process of reproduc-
tive technologies. Participants include the child, medical clinicians
and technicians, researchers, geneticists,, donors of sperm and ova,
surrogate mothers, family members, embryologists, attorneys, and
the courts. Lack of a national policy has resulted in the existence of
exploitation and commercialization of one of the most valued and
personal aspects of our society.
Many of the third parties involved in this emerging enterprise
seek to gain profits from the commercialization of procreation.3 A
national policy is required because such commercialization presents a
risk that women and children will be treated as commodities due to
specialization in the reproductive process. Such commercialization
also dictates that each aspect of the cycle from conception to birth
would be controlled by a different agent.4
Since its development, in vitro fertilization (IVF) has undergone
several variations due to scientific evolution. These include gamete
intra fallopian transfer,5 zygote intra fallopian transfer,6 superovula-
1. ROBERT H. BLANK & JANNA C. MERRICK, HUMAN REPRODUCTION, EMERGING TECH-NOLOIES,
AND CONFLICTING RIGHTS 20 (1995).
2. The Congressional Office of Technology Assessment has defined biotechnology as
"any technique that uses living organisms to make or modify products, to improve plants or
animals, or to develop micro-organisms for specific uses." OTA-F-285, OFFICE OF TECHNOLOGY
AsSESSMENT, TECHNOLOGY, PUBLIC POLICY AND THE CHANGING STRUCTURE OF AMERICAN AGRICULTURE,
31(1986).
3. BLANK& MEPRICK, SUpra note 1, at 16.
4. Id. at 17.
5. Id. at 87. Gamete intra fallopian transfer (GIFT) is a process in which the eggs are
retrieved transvaginally under ultrasound guidance, similar to IVF. However, immediately
following this a laparoscopy is performed and 3-4 eggs from the woman and the husband's
sperm is transferred into the fallopian tube.
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tion, 7 and transvaginal ultrasound-directed oocyte recovery.8  How-
ever, to thoroughly examine the controversial and complex issues
raised by technological and social innovations in human reproduc-
tion, this paper will focus specifically on IVF and similar reproduc-
tive technologies. 9
Although each of the above procedures is subject to technologi-
cal differences, there are nonetheless common characteristics among
the group which would allow them to come under the same regula-
tory scrutiny. In the absence of federal legislation, the courts are the
sole policy making institutions available to resolve related disputes.
Given the variations in policies amongst the states, the result has
been contradictory and confusing public policy.
A noted author states that "a society can safely leave important
and potentially dangerous interventions without legal regulations
only if there is a sufficient degree of moral consensus so that indi-
viduals can be expected to act morally without regulation." ° He
further adds that "legal regulation may be necessary in areas of hu-
man conduct where liberty is often abused and important moral val-
ues are in jeopardy."' I
Given the conflicting interests and motives of the various people
involved, a moral consensus would be difficult, if not impossible, to
obtain. Rights to privacy provide the key to the problem of develop-
ing a moral consensus with regard to the use of human reproductive
technology. 2 The resulting quasi-bureaucratic nature of the business
and the legal, social, and ethical issues provoked by these technolo-
gies need appropriate legislation to impose quality control standards
and to ascertain accurate record keeping and clarification of liability
6. Id. at 87. Zygote intra fallopian transfer (ZIFT) involves the process in which the
embryo is placed via a catheter in the fallopian tube about eighteen hours after fertilization.
7. JANICE G. RAYMOND, WOMEN As WoMBs 12 (1993). Superovulation is a means of in-
ducing a woman to produce a large number of eggs instead of the normal production during
monthly ovulation.
8. KENNETH D. ALPERN, THE ETmICS OF REPRODUCTI E TECHNOLOGY 26 (1992). In this pro-
cedure, eggs are obtained from the ovaries by inserting a needle through the vaginal wall rather
than through the abdominal wall.
9. Reproductive technologies encompass procreative procedures such as artificial in-
semination, surrogacy arrangements, prenatal screening, and genetic screening. These issues
and those relating to informed consent, insurance reform and abortion are beyond the scope of
this paper.
10. Carl Wellman, Moral Consensus and the Law, in THE CONCEPT OF MORAL CONSENSUS
109, 110 (Kurt Bayertz ed., 1994).
11. Id.
12. H. Tristram Engelhardt Jr., Consensus: How Much Can We Hope For?, in THE
CONCEPT OF MORAL CONSENSUS 19, 34 (Kurt Bayertz ed., 1994).
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questions.
Part II of this paper will provide background information on
IVF. Part III will analyze the abuses prevalent in the field of IVF,
including their implications and consequences. Part IV will set forth
a summary of the current status of public policy and governmental
considerations of IVF. Part V will discuss the constitutional basis for
federal regulation. Part VI will present this author's recommended
regulatory proposal.
I. BACKGROUND INFORMATION ON IVF
IVF was developed in Great Britain where the technology-
assisted birth of Louise Brown on July 25, 1978 was deemed a suc-
cess by Drs. Robert Edwards and Patrick Steptoe.'3 In the United
States, more than three million couples sought help for infertility in
1995.14 Of those, approximately 40,000 tried technology-assisted re-
production.' 5 Today, assisted reproductive technology is a billion
dollar industry and a leading combative tool against infertility, but it
is not a cure for infertility. The more well-known of the techniques is
IVF.
A. Procedures and Terminology
IVF is literally defined as fertilization in glass. 6 The procedure
begins with the surgical removal of eggs from female ovaries for fer-
tilization outside the body.17 One of two procedures is used to extract
the eggs from female ovaries: laparoscopy or oocyte recovery. In
laparoscopic egg retrieval, the woman undergoes three abdominal in-
cisions under general anesthesia.' A laparoscope, a fiberoptic
viewing tube, is inserted into the abdomen to provide the practitio-
ners with a visual advantage as the woman's ovaries are held open
with forceps.' 9 A teflon-coated needle is inserted into each of the
stimulated follicles and the woman's eggs are extracted with a vac-
13. Anette Burfoot, The Normalisation of a New Reproductive Technology, in THE New
RPRODuCTVE TECHNOLOGmS 58, 62 (Maureen McNeil et al. eds., 1990).
14. Sharon Begley, The Baby Myth, NEWSWEEK, Sept. 4, 1995, at 38,40.
15. Id. at 38.
16. Deborah Lynn Steinberg, The Depersonalization of Women Through the Administra.
tion of In Vitro Fertilisation, in TiH NEw REPRODucTvE TECHNOLOoIES 74, 77 (Maureen
McNeil et al. eds., 1990).
17. Id. at 79.
18. ALPmN, supra note 8, at 25; see also Steinberg, supra note 16, at 81.
19. ALPERN, supra note 8, at 25.
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uum pressure device.2" A more recent technological development of-
fers a nonsurgical alternative to laparoscopy. Ultrasound directed
oocyte recovery enables practitioners to direct a needle, guided by
ultrasound, through the vagina to extract the eggs.21 Oocyte recovery
is a difficult procedure because the physician must guide the needle
to the ovary without puncturing other vital organs.22
After their successful removal, the eggs are transferred to cul-
ture medium containing some of the mother's blood serum.23 Here
the eggs are maintained at constant temperature (98°F), pH, and os-
molarity, and depending on how ripe the eggs appear, sperm may be
added to the eggs immediately or as much as a day later.24 The sperm
must also be obtained and prepared for IVF.2 Sperm are prepared
for insemination by replacing the fluid part of the semen with artifi-
cial medium and holding them at room temperature for a few hours,
which increases their fertility.26 In the case of subfertile men, addi-
tional steps may be taken to concentrate and stimulate the motile
sperm, as well as to remove the dead cells and debris.27 Then, several
thousand sperm are placed in droplets of culture medium, and eggs
are transferred into the droplets.23 The eggs are examined after about
24 hours to determine the rate at which fertilization occurred, which
under normal conditions will exceed 75%.29
The development of the embryo outside the uterus is critically
important to IVF.0 Once the embryos have divided two to four
times, forming four to eight cells, two to four embryos are inserted
through a catheter into the cervix of the woman's uterus. This is re-
ferred to as embryo transfer.31 Prior to the embryo transfer, the
woman is injected with progesterone to prepare the uterus for im-
20. Id. at 26.
21. Mark Perloe, In Vitro Fertilization (IVF-E2) (visited Mar. 26, 1997)
<http://www.ivf.com/ivffaq.html>.
22. Id. at 26.
23. Gary J. Killian, Biotechnological Advances, in Bio ETHICS AND THE BEGINNING OF LIFE







30. ALPERN, supra note 8, at 26.
31. Patricia M. McShane, In Vitro Fertilization, GIFT and Related Technologies-Hope
in a Test Tube, in EMBRYOS, ETHICS AND WOMEN'S RIGHTS: EXPLORING THE NEW REPRODUCTvE
TECHNOLOGIES 31, 37 (Elaine H. Baruch et al. eds., 1988).
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plantation.32 If the embryo is introduced into the uterus too soon or
too late, implantation will not occur.33 Pregnancy is achieved if im-
plantation occurs. Although implantation is technically simple, it is a
critical process. It is at this stage that most IVF cycles are unsuccess-
ful.34 A low success rate of 21.2%31 could perhaps be due to en-
dometrial inadequacy in the uterus.36
Studies indicate that the likelihood of getting pregnant with IVF
diminishes with each consecutive attempt.37 The success rate drops
with each procedure, from 13% on the first IVF to 4.3% by the fourth
try.38 Despite these discouraging statistics, many women return for
two, five, and some for more than ten cycles.
39
B. Variations of lIV
Modem reproductive technologies have provided society with
options and hope for those who otherwise will not be able to con-
ceive. In 1993, the United States had over 267 IVF institutions40 with
a large number of these operating for profit.41 An estimated 31,900
IVF treatment cycles occur within these clinics annually. 42 Unfortu-
nately, less than 15 percent of these treatment cycles lead to a live
birth.43 Consequently, the need for research to perfect these proce-
dures and minimize risks to women is great.




35. Begley, supra note 14, at 40.
36. The endometrium is the uterine lining. Normal preparation of the endometrium is
essential for embryo implantation and early pregnancy maintenance. Because of the high es-
trogen levels resulting from the hormonal ovulation induction, endometrial inadequacy can be
seen in a number of women. McShane, supra note 31, at 37.
37. Geoffrey Cowley, The Future of Birth, NEWSWEEK, Sept. 4, 1995, at 42, 45.
38. Id.
39. RAYMoND, supra note 7, at 8.
40. AMERICAN SoCIETY FOR REPRODUCTIVE MEDICINE, ASSISTED REPRODUCTIVE TECHNOLOGY IN
THE UNITED STATES AND CANADA: 1993 RESULTS GENERATED FROM THE AMERICAN SOCIETY FOR
REPRODUCTIVE MEDICINE/ SOCIETY FOR ASSISTED REPRODUCTIVE TECHNOLOGY REGISTRY, 64 FERTILITY
AND STEnrrnY No.1, 13 (July, 1995) [hereinafter 64 FERTILITY AND STERILrr No. 1. This study
found that out of 31,900 IVF cycles/procedures, only 6,321 resulted in pregnancies with only
5,103 deliveries. Out of 4,992 GIFT cycles/procedures, there were 1,472 pregnancies with
1,182 deliveries. Finally, with 1,792 ZIFT cycles/procedures, there were only 466 pregnancies
with 380 deliveries.
41. Raymond, supra note 7, at 8.
42. 64 FERTILITY AND STERILITY NO. I, supra note 40, at 15.
43. JOHN A. ROBERTSON, CHILDREN OF CHOICE: FREEDOM AND THE NEw REPRODUCTIVE
TECHNOLOGIES 9 (1994).
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to the development of several variations of IVF such as GIFT,4
ZIFT,45 and superovulation with fertility drugs. Metrodin and Pergo-
nal are hormone drugs used to superovulate women on IVF programs
so that they produce multiple eggs.46 These drugs can result in in-
creased ovulation with multiple gestations and premature delivery or
pregnancy loss.47 The dangers of superovulation are the resulting
overstimulation and enlargement of a woman's ovaries with potential
rupture, cysts, and cancer.48
Pregnancy rates with GIFT are reported to be 5 to 10% higher
than with IVF.4 9 There is a noted advantage of GIFT for women aged
forty and over whose eggs are more sensitive to external conditions
that may influence the egg's likelihood of achieving a pregnancy.
50
Although this procedure allows for a more natural process of fertili-
zation, since it occurs in the woman's body rather than a glass dish,
the disadvantage is the necessity of a laparoscopy5t and the increased
risk of having multiple pregnancies that can lead to a wide array of
medical and psychological complications. 2
ZIFT, a hybrid of IVF and GIFT, involves vaginal egg retrieval
and fertilization in the laboratory after which time the embryo is re-
placed directly into the fallopian tube rather than the uterus through
laparoscopy.53
This increase in scientific knowledge and technological abilities
is accompanied by equally significant problems and controversies.
The following sections will discuss the intense debates focused on
the consequences of these technological developments and the ethi-
cal, social, and legal implications of IVF.
44. BLANK& MERRICK, supra note 1, at 87.
45. Id.
46. BAY AREA FERTILITY MEDICAL GROUP, PERGONAL AND METRODIN (posted Sept. 17, 1995)
<http://www.ihr.comlbafertillarticles/pergmetr.html>.
47. Id.
48. RAYMoND, supra note 7, at 13.
49. Begley, supra note 14, at 41.
50. BAY AREA FERTrIIY MEDICAL GROUP, IVF versus GIFT versus TET (posted Sept. 17,
1995) <http://www.ihr.com/bafertil/articles/ivfvsgif.html>.
51. Atlanta Reproductive Health Centre, Laparoscopy (visited Mar. 6, 1997)
<http://www.ivf.com/larrsepy.html> (Laparoscopy is a surgical procedure where an incision is
made in the area of the umbilicus (navel), and a telescope-like instrument (laparoscope) is in-
serted and used to view the ovaries. The ovarian follicles, which contain the mature eggs, are
located and using a special needle, the fluid inside each follicle is suctioned out).
52. BLANK& MERRICK, supra note 1, at 91.
53. Id.
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III. ABUSES AND CONCERNS
A. The Fates of Surplus Embryos
Given the market demands for IVF utilization by infertile cou-
ples for whom the procedure is their final means of having a biologi-
cal child together and the absence of procedural controls over IVF
clinics, severe abuses of IVF have occurred. One of the most contro-
versial issues deals with the treatment of surplus embryos.
During a woman's initial IVF cycle, three to four of the embryos
created are transferred to the uterus.54 Implantation of multiple em-
bryos increases the possibility of multiple pregnancies.5 5 One study
noted that "at the time of the procedure 88 women had triplets, 89
had quadruplets, 16 had quintuplets, and 7 had from 6 to 9 fetuses.
These pregnancies were reduced to 189 sets of twins, 5 sets of trip-
lets, and 6 singletons .... ,"56 The result of these multiple pregnancies
is that fetal reduction is used to terminate a certain number of fe-
tuses.57 Since fetal reduction terminates the pregnancy, legal issues
similar to those regarding abortion are implicated.
Other legal issues arise with regards to the cryopreservation58 of
remaining embryos for thawing and transfer at a later date.59 The ra-
tionale provided by doctors in favor of freezing embryos is that it is
in the best interests of the patient to maintain a reserve.6" However,
accessibility to the reserves presents the problem of unauthorized use
of the embryos for research, donation, and discard.61  While some
IVF programs permit the couples to decide the destiny of their extra
embryos, other programs apply strict policies conforming either to
54. McShane, supra note 31, at 37.
55. BLANK & MERRICK, supra note 1, at 92.
56. Id.
57. RAYmoND, supra note 7, at 14. Fetal reduction is where the pregnancy is !erminated,
similar to an abortion.
58. ROBERT H. BLANK, REGuLATnNG REPRODUCTION 67 (1990). Cyropreservation involves
freezing of the embryos upon reaching the two-eight cell stage of division. They are then
gradually cooled to minus 196 degrees Celsius and stored in liquid nitrogen until time for im-
plantation when they are thawed and placed in the uterus.
59. Mina Alikani, Preservation of Human Eggs and Embryos Through Freezing, in
ISSUES IN REPRnODucTVE TECHNOLOGY I: AN ANTHOLOGY 201 (Helen B. Holmes ed., 1992).
60. See generally Andrea Bonnicksen, Ethical Issues in the Clinical Application of Em-
bryo Freezing, in IssUEs IN REProoucmar TECHNOLOGY I: AN ANTHOLOGY 217 (Helen B. Holmes
ed., 1992).
61. ROBERTSON, supra note 43, at 107. See also Aila Collins & Judith Rodin, The New
Reproductive Technologies: What Have We Learned?, in WOMEN AND NEw REPRODUCTIVE
TECHNOLOGIES 159-160 (Judith Rodin & Aila Collins eds., 1991).
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their moral views or institutional constraints.62
Despite these formal policies, the practice of using preserved
eggs in other women who are unable to produce their own eggs has
been widely exploited by clinics and physicians. Until October 1996,
embryo theft was not a criminal offense in California. Recent alle-
gations of physicians stealing eggs from anesthetized women for sub-
sequent implantation in other infertile women has led to closer scm-
tiny.63 In June 1995, the once famous Center for Reproductive Health
at U. C. Irvine, California, was forced to close its doors after charges
of improper egg and embryo handling.64 Rapid growth of IVF serv-
ices increases the possibility that clinics will be improperly staffed or
will not maintain rigorous quality control, resulting in such exploita-
tion.
In response to the U.C. Irvine situation, Senator Tom Hayden
authored a bill making it a felony to transplant eggs without donor
consent.6  The California legislature passed the bill in 1996, thus
criminalizing such unethical and abusive practice. 66 This bill makes
it a felony punishable by up to five years in prison and/or a fine of up
to $50,000 to knowingly use sperm, ova, or embryos in assisted re-
production without written consent of the donor and recipient, except
in the case of sperm donations to licensed tissue banks.67
Furthermore, California State Assemblywoman Jacqueline
Speier authored a bill related to the consent issue in reproductive
technologies which was also passed by the legislature in 1996.68 This
bill requires a physician who removes sperm or ova from a patient, to
obtain the patient's written consent prior to using the sperm or ova
for purposes other than reimplantation in the same patient or implan-
tation in the patient's spouse. 69 Violation of the bill's provisions con-
stitutes unprofessional conduct, not a misdemeanor, and subjects a
62. ROBERTSON, supra note 43, at 108.
63. New Allegations Against Fertility Clinics, S.J. MERCURY NEws, Nov. 12, 1995, at A2.
64. Nina Martin, Scrambled Eggs, CAL. LAw., Oct. 1995, at 21-22. See also S.J.
MERcuRY NEws, Jan. 20, 1997 at B3. Dr. Sergio Stone, one of the doctors involved in the sto-
len eggs scandal faces only mail fraud charges when his trial begins on Tuesday January 20,
1997. Even though seven to twelve children are believed to have been born from the misap-
propriated eggs, Stone does not face criminal charges in connection with such reproductive
theft because at that time, there was no law against it. Two other doctors involved in the scan-
dal, Dr. Asch and Dr. Balmaceda fled the United States before they could be arrested.
65. S.B. 1555, 1996 Reg. Sess. (Cal. 1996).
66. CAL. PEN. CODE § 367g (West Supp. 1996).
67. S.B. 1555, 1996 Reg. Sess. (Cal. 1996).
68. A.B. 2513, 1996 Reg. Sess. (Cal. 1996).
69. Id.
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physician who violates the bill to civil penalty payable to the person
whose required consent was not obtained. Such penalties range from
$1,000 to $5,000 plus court costs for a second violation.7° While this
is encouraging, many other states have not followed suit.
B. Who Controls the Frozen Embryos?
Cryopreservation is further complicated when the parental bond
between couples is terminated as a result of divorce, separation, or
death. The legal status of embryos receives different treatments in
the lower courts nationwide. The emerging technologies raise ques-
tions that have yet to be resolved in the courts. The existing statutes
and constitutional theories have become less and less adequate to
protect reproductive choice. Thus, the need for regulation on these
issues is urgent to avoid results similar to those described below.
In Davis v. Davis,7' the genetic father fought with the genetic
mother after their divorce regarding the disposition of seven frozen
embryos that remained after their earlier attempted use of IVF. Mrs.
Davis argued that she had the authority over the disposition of the
frozen embryos.72 She asserted that she could have them transferred
to her in order to become pregnant or she could give permission to
have them transferred to another woman.73 Mr. Davis, who did not
want to have children, argued that he had a say over the disposition
of the pre-embryos and thus could veto his ex-wife's decision.74
The trial court awarded custody of the pre-embryos to Mrs.
Davis, finding that frozen pre-embryos were human beings and
should be handled in a custody dispute as children. 75 Reversing the
trial court decision, the Tennessee Court of Appeals stated that
awarding custody to Mrs. Davis violated Mr. Davis's constitutional
right not to beget children.76 The Court of Appeals awarded joint
custody over disposition of the pre-embryo. 77
The Supreme Court of Tennessee rejected both the notion that a
pre-embryo is a legal person and that it is a form of property to be
disposed of as is other property in a divorce case.78 Instead, the court
70. L.
71. 842 S.W.2d 588 (Tenn. 1992), cert. denied, 113 S.Ct. 1259 (1993).
72. Id. at 592.
73. Id.
74. Id.
75. Davis v. Davis, No. E-14496 (Tenn. Cir. Ct. Eq. Sept. 21, 1989).
76. Davis v. Davis, No. 180 (Tenn. Ct.App. Sept. 13, 1990).
77. Id.
78. Davis v. Davis, 842 S.W.2d 388, 597 (1992).
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held that pre-embryos "occupy an interim category that entitled them
to special respect because of their potential for human life. ' 79 Both
the husband and the wife, as gamete providers, wdre held to have
"decision making authority concerning the disposition of the pre-
embryos, within the scope of the policy set by the law." 0 The court
stated that a prior agreement between the couple for disposition of
the frozen embryos in the case of divorce would need to be en-
forced.8 Since there was no prior agreement between the husband
and wife, the court had to decide which of the two gamete providers
would prevail in this dispute. The husband's desire to avoid "genetic
parenthood" was given preference in Davis due to the fact that he
should not be compelled to become a father against his will. The
court opined that "the technological fact that someone unknown to
these parties could gestate these pre-embryos does not alter the fact
that these parties, the gamete providers, would become parents in that
event .... Ordinarily, the party wishing to avoid procreation should
prevail, assuming that the other party has a reasonable possibility of
achieving parenthood by means other than use of pre-embryos in
question."82
In justifying its decision, the Tennessee Supreme Court pointed
to alternatives available to the woman such as adoption and IVF cy-
cles with a new partner.8 3 The Court further stated that if the party
seeking control of the pre-embryos intends merely to donate them to
another couple, the objecting party obviously has the greater interest
and should prevail.' The Davis case illustrates that a woman's rights
may be considerably diminished by these new technologies because a
woman who chooses to freeze her eggs may not be able use them
later if the biological father does not want to be a parent.
In contrast, a Virginia court in York v. Jones" ruled on an in-
junction regarding the disposition of a pre-zygote and concluded that
the pre-zygote was defined as property and therefore lacked a moral
status.86 Declining to give the embryo any moral status, the court de-
nied the embryo the benefit of any rights. In Jones, the couple had




82. 842 S.W.2d at 603-04.
83. Id. at 604.
84. Id.
85. 717 F.Supp. 421 (E.D.Va. 1989).
86. Id. at 425-26.
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gram in Virginia that they wished to transport their frozen embryos to
California to be thawed and placed in the wife by their Californian
physician.8 7 Upon refusal by the Virginia program to follow the cou-
ple's instructions, the couple sued the clinic.88 The court ruled on the
assumption that the embryos are the property of the gamete providers
and found that any transfer of their ownership rights must be explic-
itly documented. 9 Relying on the terms of the agreement between
the Yorks and the clinic, the court found that the Yorks had limited
their choices regarding the disposition of their embryos." Nonethe-
less, the York court, finding that a bailment relationship existed be-
tween the Yorks and the clinic, agreed that the clinic must agree to
the transfer because the frozen embryos were the property of the
Yorks.91
These two cases illustrate that courts are not consistent in their
treatments of frozen embryos. Some federal regulation is necessary
to clarify the legal status of the frozen embryos to avoid further con-
fusion and inconsistency in the law.
C. Ethical Concerns
In addition to raising legal issues, the freezing of embryos raises
additional conflicts between the ethical dimensions and technological
capabilities of IVF. In 1990, 23,865 embryos were frozen as a result
of the IVF process, an approximate 62% increase from 1988.92
Cryopreservation permits the combination of germ cell materials
from persons of different generations. 93 Consequently, identical
twins may be created years or even generations apart, thus challeng-
ing the structure of family relationships. 94 As well, the ethical con-
cerns are related to the length of storage and the consequent harm to
the embryo cells. Frozen-thawed embryos divide and result in preg-
87. Id. at 424.
88. Id.
89. Id. at 427.
90. Id. at 425.
91. York, 717 F.Supp. at 425.
92. RoBERTsoN, supra note 43, at 109. Not only can the embryos be frozen but so can the
unfertilized eggs. The issue arises due to the fact that embryos can survive for many years
through cyropreservation, however, unfertilized eggs are extremely fragile and more than half
of those frozen disintergrate upon thawing. Those that survive can be fertilized, but the re-
sulting embryos rarely develop properly or implant in the womb. They are more likely to be
aborted as they gestate. Cowley, supra note 37, at 42.
93. BAnK & MERRCK, supra note 1, at 88.
94. Id.
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nancies at a lesser rate than do fresh embryos.95
D. Administrative Concerns
Not only do IVF procedures raise legal and ethical issues, the
monitoring and reporting of successful IVF procedures also implicate
administrative concerns. Methods of reporting significantly influ-
ence the derivation of the actual success rate. A national success rate
has been difficult to determine because most IVF clinics have differ-
ing definitions of IVF successes and, therefore, differing reporting
methods. In figuring the total pool from which to derive the success
rate, some clinics consider all applicants including women who
dropped out of the program, regardless of the reasons for withdrawal,
while others base their success rates on clinical pregnancy per at-
tempted egg recovery trial rather than on live births.96 The variance
in success rates lures hopeful women to the IVF institutions and en-
courages extensive financial and emotional investments in programs
with questionable credibility.
The need to provide IVF consumers with accurate information
was championed by Congressman Ron Wyden who demanded uni-
form reporting of IVF success rates." Congressional hearings by
Representative Wyden on the efficacy and competence of IVF pro-
grams were initiated.9" As a result of the hearings, the Fertility Clinic
Success Rate and Certification Act was enacted in 1992, mandating
that live birth rates be reported annually to the Centers for Disease
Control.99
Nevertheless, budget constraints have not allowed this program
to be implemented. Although the American Society for Reproductive
Medicine (ASRM)100 and the Society for Assisted Reproductive
Technology (SART) now maintain a database of various IVF clinics
that voluntarily submit their information, there is no mandatory re-
95. Ia at 110.
96. RAYmoND, supra note 7, at 11.
97. Id. at 115.
98. Consumer Protection Issues Involving In Vitro Fertilization Clinics: Hearings Before
the Subcomm. on Regulation and Business Opportunities of the House Comm. on Small Busi-
ness, 100th Cong. 33 (1988) (statement of Richard Marrs, Director of the Reproductive Center
at Good Samaritan Hospital, concluding that "regulatory control is badly needed because of
the proliferation of centers doing IVF.")
99. 42 U.S.C. § 263a-7 (1988 & Supp. IV 1992). The Act defines the live birth rate as
the ratio of live births divided by the number of ovarian stimulation procedures tried at each
program, and the number of successful egg retrieval procedures performed by each program.
Id. § 2(b)2(A), (B).
100. Formerly The American Fertility Society.
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quirement that all IVF clinics contribute their statistics to this
ASRM-SART database."' The ASRM, composed of clinicians and
researchers involved with these technologies, claims to monitor it-
self.' 2 Although being a SART member requires a clinic to report its
statistics to the registry, the problem is that many clinics are inactive
or are not SART members.'03 Obtaining an accurate consensus on
success rates is further complicated because many physicians who
own and operate their own businesses are not compelled to report any
data. '4  The SART guidelines for professional IVF clinicians only
sets minimum standards and have no authority behind them to ensure
compliance. Enforceable federal regulations, including legal sanc-
tions for violations, are necessary to ensure compliance 05
E. Economic and Socioeconomic Concerns
The concerns raised by IVF are certainly not limited to the legal,
ethical, and administrative realms; on a more personal front, eco-
nomic and socioeconomic issues must be addressed. A mere 10% of
the women who ascribe to the IVF treatments are rewarded with
pregnancies and the joys of motherhood. 06 Despite this low "return
on investment," women continue to spend as much as $50,000 on
IVF programs. 07 At an estimated $8,000 to $12,000 cost per IVF cy-
cle, it is easy to determine that the profitability of private clinics is a
function of the number of cycles serviced.' °0 Aggressive marketing
techniques with exaggerated success rates are an all too common
means of luring desperate and vulnerable parent-hopefuls. Although
the use of sophisticated reproductive technologies justifies a portion
of the medical fees, clinics are not shy about relying on the emotional
desperation of childless couples to inflate the asking price. The high
cost of reproductive technologies and lack of standard regulations
101. John Collins et al., An Estimate of the Cost of in vitro Fertilization Services In the
United Stated in 1995, 64 FERTmTY An SmTErrny No. 3, 539 (Sept. 1995) [hereinafter 64
FERTiLrr AN SEn.rny No. 3].
102. RAYMoND, supra note 7, at 12.
103. 64 FERmrrTY AND STuLrry No.l, supra note 40, at 18.
104. 64 FERnLrrv AND STEiLrrY No.3, supra note 101, at 539.
105. BLAN & MERuc, supra note 1, at 21.
106. Peter J. Neumann et al., The Cost ofA Successful Delivery with IVF, 331 NEw ENo. J.
MED. 239 (1994).
107. BLANK & MEiucr,, supra note 1, at 89. See also, Begley, supra note 14, at 40.
(Fertility drugs, diagnostic tests, laprascopy costs, surgery fees are examples of the costs in-
volved).
108. Diane M. Gianelli, Fertility Clinic: Baby in Three Tries or Your Money Back, AM.
MED. NEws, Sept. 25, 1995, at 4.
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allow the providers of IVF ample opportunities to exploit and profit
from the resources. 109
The costs associated with reproductive technologies present ad-
ditional problems on a socioeconomic level. Social factors are im-
portant determinants of acceptance and resistance to technological
innovations, of how these innovations emerge and are disseminated,
and of whom they affect."' Reproductive technologies provide
choices for affluent middle-class couples who are free to give in-
formed consent for their use; however, the same privilege is denied to
the less affluent."' The potential IVF patient selection criteria util-
ized by many clinics such as age, marital status, and financial ability
are additional obstacles to overcome. Furthermore, many states ex-
clude such services as IVF under the Medicaid program.1 Hence,
for poor women, who have higher infertility rates than upper-middle
class women, access to such technologies is slim.'
A couple of factors have affected the unavailability of reproduc-
tive technologies to the lower class: the lack of insurance coverage
for such procedures and the lack of Congressional initiatives to pro-
vide the infertile poor with alternative means of affording the tech-
nologies." 4 While insurance companies will not pay expenses for di-
agnosis of infertility, they may pay for "diseased-sounding
diagnosis." Over $1 billion is spent annually on health care to try to
help infertile couples get pregnant."5 Some is paid by insurance
companies only because of diagnoses that are used by health provid-
ers to disguise the word "infertility."' 116
In a 1992 policy statement, The American Fertility Society
(AFS) and The American College of Obstetricians and Gynecologists
(ACOG) recognized infertility as "disease resulting in the abnormal
function of the reproductive system.""' 7 Despite this recognition of
infertility as a disease, the United States Congress has not acted to
109. Burfoot, supra note 13, at 69.
110. See generally BLANK & MrEnucK, supra note 1.
111. BLANK & MErnucK, supra note 1, at 227.
112. Ruth S. Hanft, New Reproductive Genetics: Political Issues, 36 CLNCAL OBsTmics
AND GyN coLoGy No. 3, Sept. 1993, at 598.
113. Ellen Wright Clayton, Women and Advances in Medical Technologies: The Legal
Issues, in WOMEN AND NEw REPROoUCnvE TECHNOLOOIES 92 (Judith Rodin & Aila Collins eds.,
1991).
114. See generally Clayton, supra note 113, at 92.
115. CA tAHAs Wss, THE h n'a Tnrr BoOK 41 (1992).
116. Id.
117. RESOLVE, INC. & THE AMEICAN FERTILrIY SociEY, INFERTIrrY AND NATIONAL HEALTH
CARE REFORM: A BRIFING PAPER 1 (1993)
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regulate IVF nor to mandate funding of treatments under health in-
surance policies. Treating infertility like any other disease would
mean that it would have to be covered under insurance as a health
risk. A projected cost of adding IVF to a standard health care bene-
fits package in 1995 would be $2.79 per year and the premium would
be $3.14.118 This illustrates that the cost of IVF services would be a
small fraction of the annual cost of a typical family benefits pro-
gram." 9 As costs escalate due to inflation, technological advances
and decreases in insurance coverage, increasing numbers of Ameri-
cans are being priced out of infertility treatments.12 0 This creates a
disparity in that the rich benefit from IVF whereas the poor are
forced, economically, to eliminate IVF as an option.
In response to this crisis, consumer groups have actively pur-
sued legislative insurance reform, arguing that infertility coverage
would not siguificantly increase insurance industry costs.' 2' Eight
states currently have laws addressing insurance coverage for IVF
treatment specifically." The California legislature has made explicit
judgment that, although infertility is a medical condition that group
insurance should cover, coverage of IVF treatment should not be
mandated." Arkansas, Connecticut, Hawaii, Illinois, Maryland, and
Texas have adopted statutes that explicitly include IVF treatment in
either a mandate to offer 24 or a mandate to provide.'12
The courts have been struggling with the interpretation of health
insurance contracts and the provisions regarding coverage of infertil-
ity procedures, usually in regard to reimbursement of assisted repro-
ductive technologies (ART). A few of the decisions have affirmed
insurance companies' denials of coverage of ART the other infertility
procedures. 26 However, several decisions favored reimbursement of




122. Note, In Vitro Fertilization: Insurance and Consumer Protection, 109 HARv. L. Rv.
2092,2095 (1996).
123. See CAL. HmT. & SAFETY CODE § 1374.55(a) (West Supp. 1996). The law mentions
only group health service plans and thus does not apply to health maintenance organizations
(HMOs), individual health insurance plans, or public health insurance.
124. See CONN. GEN. STAT. § 38a-536 (1995); Tax. INS. CODE ANN. art 3.51-6, 3A(a) (West
Supp. 1996).
125. See ARK. CODE ANN.§23-85-137, 23-86-118 (Michie 1992); HAw. Rv.
STAT. § 431:10A-1 16.5, 432:1-604 (1993); ILL. COMp. STAT. ch. 215, 5/356m(a) (Smith-Hurd
1993); MD. CODE ANN., INS. 354DD, 470W, 477EE (1994).
126. See Thomas v. Track Drivers & Helpers Local No. 355, 771 F. Supp. 714 (D. Md.
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these claims and obligated the insurer to pay.127
IV. CURRENT IVF POLICIES AND GOVERNMENT INVOLVEMENT
Policy on IVF today combines self-regulation by the private
sector, existing laws designed to protect subjects of research, and a
few state laws dealing directly with IVF. While some states recog-
nize the need to regulate in this area, many states do not. This is the
source of the inconsistent outcomes in legal disputes resulting in
continued unethical practices in the business.
A. Assisted Reproductive Technology Act
The phenomenal growth of the industry and its technological
advances have been supported primarily by private funding.128 There
has been little effort by the states or the federal government to fund
assisted reproduction. Existing federal involvement in IVF gives the
Secretary of Health and Human Services the power to oversee as-
sisted reproductive technologies. 129
On October 24, 1992, the Assisted Reproductive Technology
Programs Act (the ACT) was enacted to address such issues as re-
porting of success rates to the Secretary through the Centers for Dis-
ease Control.1 30 In addition, the ACT required the Secretary to de-
velop a model program for the certification of embryo laboratories to
be carried out by the states,"3 to distribute a description of the certifi-
cation program to government officials of each state, and to encour-
age such officials to assist the state in adopting the program. 132
Unfortunately, the ACT does not mandate states to implement a
certification program. If a state wishes to adopt the certification pro-
gram it must first submit an application to the Secretary, who retains
the authority to approve or reject the certification request. 33  On its
face, the ACT appears to be an appropriate measure to regulate IVF
1991); Maciosek v. Blue Cross and Blue Shield, 930 F.2d 536 (7th Cir. 1991); Kinzie v. Phy-
sicians Liab. Inc. Co., 750 P.2d 1140 (Okl. Ct. App. 1987).
127. See Ralston v. Connecticut Gen. Life Ins., 617 So.2d 1379 (3d Cir. 1993); Egert v.
Connecticut Gen. Life Ins., 900 F.2d 1032 (7th Cir. 1990); Reilly v. Blue Cross and Blue
Shield United of Wis., 846 F.2d 416 (7th Cir. 1988); Witcraft v. Sundstrand Health & Disabil-
ity Group, 420 N.W.2d 785 (Iowa 1988); Regnier v. Industrial Comm'n of Ariz., 707 P.2d 333
(Ariz. Ct. App. 1985).
128. SHEM-A SILEa, M.D., How To GET PREGNANT Wrm THE NEw TECHNOLOGY 32 (1991).
129. 42 U.S.C. §§ 263a-7, 263b (1988 & Supp. IV 1992).
130. 42 U.S.C. § 263a-l(a)
131. 42 U.S.C. § 263a-2(a).
132. 42 U.S.C. § 263a-2(b).
133. 42 U.S.C. § 263a-2(e).
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because it provides for guidelines and standards to assure consistent
performance of procedures by each embryo laboratory under the cer-
tification program, 3 4 to assure a quality control program, 35 and to
provide for a standard for the maintenance of records on laboratory
tests and procedures performed. 36 Nonetheless, the ACT fails to
protect the interested parties of IVF because the Secretary does not
have any power to establish any regulation, standard, or requirement
that has the effect of exercising supervision or control over the prac-
tice of medicine in assisted reproductive technology programs. 37
Consequently, the IVF practitioners are free to perform procedures
for profit without governmental regulation.
Additionally, clinics may continue to operate regardless of
whether or not the states apply to the certification program or receive
certification approval from the Secretary. Consequently, the estab-
lishment of a voluntary certification program by Congress for em-
bryo laboratories fails to fulfill the existing need for clinics' stan-
dardization and internal control. Furthermore, the program, to be
monitored by the Centers for Disease Control, has not gone into ef-
fect because of budget constraints. 38 Thus, the abuses continue due
to lack of any comprehensive regulation of the IVF procedures in the
various states. 39
Unlike the United States, the United Kingdom recognizes the
importance of regulation and an active government role in the treat-
ment of infertility. 140 In 1992, an estimated one out of every six cou-
ples was infertile in the United Kingdom. The total number of
women with impaired fertility was 5.3 million, or 9.1% of all women
aged 15-44.11 The U.S. need for research in infertility is similar to
that of the United Kingdom, and it would seem appropriate to spend
some of the money used in the assisted reproductive technology
business for research to determine the causes of infertility in the
134. 42 U.S.C. § 263a-2(d)(1).
135. 42 U.S.C. § 263a-2(d)(2).
136. 42 U.S.C. § 263a-2(d)(3) (1992).
137. 42 U.S.C. § 263a-2(I).
138. Diane M. Gianelli, Fertility Scandal Raises Call for Regulation, AM, MED. NEws
Sept. 11, 1995, at 3,29.
139. In the United Kingdom, the regulation ofIVF is rigorous and all centers must report
all treatment cycles on all patients indicating exactly what was done. See Gianelli, supra note
138, at 29. Unlike the United States, the Minister of Health in Victoria, Australia regulates the
clinics where IVF procedures are performed pursuant to the Infertility Act of 1986. See Rptr.
H.R.L. No. 20,231-2 (1989).
140. See BLANK, supra note 58, at 143-144.
141. BLANK& MERmK,supra note 1, at 85.
1997] ASSISTED REPRODUCTIVE TECHNOLOGIES 535
United States.
IVF is merely a solution to childlessness, not a cure for infertil-
ity. 42 The causes of infertility include environmental, heritable,
pathological, and sociobehavioral factors. 43 By keeping the federal
government involved in the research of infertility and assisted repro-
ductive technologies, rather than just using private funds, debate of
the issues surrounding IVF and other reproductive technologies and
research findings would be kept in the public domain. This would
also benefit potential users of such technologies because they would
have accurate and current information which would allow them to
better give their informed consent when undergoing such treatments.
The call for federal regulation of IVF programs is justifiable.
As "consumers" of IVF technologies, couples are oftentimes too
emotionally involved to maintain an objective and cautious stance
toward the practices of institutions and individuals providing the
service. But the federal government has done nothing except to sug-
gest regulating licensing of IVF clinics by the voluntary certification
program. 44 Protecting consumers from fraud, misrepresentation, and
incompetent practitioners by implementing a uniform regulatory
scheme nationwide is necessary. Unethical conduct by doctors who
use women and their gametes and embryos as commodities to make a
profit must be addressed by the federal government as a national
policy.
B. Research
Federal interest in IVF peaked at approximately 1979, but after
the Department of Health, Education and Welfare failed to approve
the application for research that formed the basis of the report of the
Ethics Advisory Board, federal interest in IVF waned. 14 In 1980, the
Ethics Advisory Board dissolved, creating what has been character-
ized as "an official moratorium on all Federal funding and oversight
of IVF research.'1146 In 1988, the Department of Health and Human
Services reconstituted the Ethics Advisory Board147 at the same time
the Office of Technology Assessment issued its comprehensive re-
142. Id.
143. Id.
144. SMEr, supra note 128, at 327. See also supra text accompanying note 129.
145. Jean Macchiaroli Eggen, The "Orwellian Nightmare" Reconsidered: A Proposed
Regulatory Frameworkfor the Advanced Reproductive Technologies, 25 GA. L. Rsv. 625, 625.
146. lId at 685.
147. 53 FED. REo. 35,232-33 (Sept. 12, 1988).
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port on infertility.'48 Legislation was passed in 1993 which made it
possible to fund IVF research once again. 149 The Embryo Research
Panel of the NIH was commissioned subsequent to this legislation to
provide recommendations on federal funding for embryo research. 5°
However, within hours of receiving the panel's recommendations,
President Clinton ordered the NIH not to spend any federal funds to
create embryos for research.'
Undoubtedly, research in the private sector will continue re-
gardless of the availability or lack of federal funds. But, the failure
of the federal government to fund IVF research has placed the re-
search outside of public control and into private control. Federal
funding of IVF research would place the heated debates in the public
arena and allow for more control and focused goals in the research.
V. THE CONSTITUTIONAL BASIS FOR IVF REGULATION
IVF technology focuses on the earliest stages of human life.
The United States Supreme Court has held that the freedom to decide
whether or not to have children and to control the use of one's repro-
ductive capacity is a valuable right.'52 In Griswold v. Connecticut,
the Court found a state law pronouncing the use or distribution of
contraceptives to be a crime unconstitutional.153 In maintaining the
right of persons to avoid reproduction through contraception, the
Court established a general principle that reproductive choice is a
fundamental liberty right of married couples and, as later extended,
of unmarried couples.154
Under Roe v. Wade,'55 whose central holding was reaffirmed in
1992 in Planned Parenthood v. Casey,5 6 women, single or married,
148. The Office of Technology Assessment (OTA) conducted a study of IVF programs in
the United States and concluded that approximately half have not reported a single birth.
OTA-BA-358, OFFICE OF TECHNOLOGY AsSESSMENT, INFERTrrv: MEDICAL AND SOCIAL CHOICES
(1988). The study of infertility and reproductive technologies commenced by the OTA was an
efficient means of bringing awareness of the issues to members of Congress. But with the re-
cent budget cutbacks, the OTA no longer exists to influence Capitol Hill.
149. National Institutes of Health Revitalization Act of 1993, Pub. L. No. 103-43, § 1001,
107 Stat. 122, 165 (1993) (codified at 42 U.S.C. § 285g-5 (1994).
150. Id
151. Clinton Orders NIH Not to Fund Creation of Research Embryos, Hous. CHRON., Dec.
3, 1994, at A23.
152. Griswold v. Connecticut, 381 U.S. 479 (1965).
153. Id. at 485.
154. Id. at483.
155. 410 U.S. 113 (1973).
156. 505 U.S. 833 (1992).
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adult or minor, have a right to terminate their pregnancy up to viabil-
ity. Alas, Casey allows states to discourage abortion through reason-
able waiting periods before obtaining an abortion, informed consent,
and other regulatory requirements, thus modifying the rigid protec-
tion provided for in Roe by establishing a stricter test.15
7
Procreative liberty is a right against government interference
with choices to procreate or to avoid procreation. 58  Therefore, it
would seem logical that any restriction or regulation of these tech-
nologies would interfere with or limit procreative freedom. Hence,
the law's recognition of a right to avoid reproduction provides the le-
gal framework for resolving conflicts presented by the new repro-
ductive technologies such as IVF.
In applying the above cases to IVF, a law banning IVF would
undoubtedly be found unconstitutional because it would interfere
with the right to procreate. Nevertheless, the objective in this in-
stance is not to ban but to regulate the IVF clinics and its practitio-
ners so that consumers are not exploited by false and misleading sta-
tistics and information. The federal government must play a role in
ensuring that persons who choose IVF have accurate information
about the pros and cons of IVF treatment and are provided with better
protection against the risks inherent in the treatment process.
One of the reasons why the federal government should be in-
volved in IVF research is to protect women against the potential harm
from IVF procedures. The risk IVF procedures include ovarian hy-
perstimulation syndrome and heightened incidence of breast, genital,
and hormone-dependent cancer linked to superovulation. 59 If the
federal government funds the research in this field, as it already funds
other biomedical fields under the NIH,60 then federal regulation and
supervision of IVF would be possible. Federal support of IVF re-
search and practice would facilitate federal regulation of the proce-
dure. Considering that the right to procreate or not to procreate is a
fundamental right '6 and that various products dealing with reproduc-
157. The Casey majority held that, "Our law affords constitutional protection to personal
decisions relating to marriage, procreation, contraception, family relationships, childbearing
and education... [These] matters, involving the most intimate and personal choices a person
may make in a lifetime, choices central to personal dignity and autonomy, are central to the
liberty protected by the Fourteenth Amendment:' Id. at 851 (citation omitted).
158. ROBERTSON, supra note 43, at 23.
159. Joseph G. Schenker & Yossef Ezra, Complications of Assisted Reproductive Tech-
nologies., 3 FERTILITY & TE R rn- No. 6,411-12 (1994).
160. E.g., The Human Genome Project.
161. See generally Roe, 410 U.S. 113; Casey, 505 U.S. 833.
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tion are already being marketed, t6 2 Congress' constitutional com-
merce power would be a viable means by which to regulate IVF pro-
cedures. 163
In a similar exercise of its Commerce Clause power, Congress
enacted the National Organ Transplant Act (Transplant Act) in
1984.161 Title III of the Transplant Act provides that "it shall be un-
lawful for any person to knowingly acquire, receive, or otherwise
transfer any human organ for valuable consideration for use in human
transplantation if the transfer affects interstate commerce."' 65 The
"human organ" is defined as "the human kidney, liver, heart, lung,
pancreas, bone marrow, cornea, eye, bone or skin.' 66  Violation of
the Transplant Act means a five year maximum prison term plus a
$50,000.00 fine. 167  Since it would probably be too far fetched to in-
terpret "human organ" to include frozen embryos and given the high
risk of abuse in this area, Congress needs to enact a separate compre-
hensive regulation dealing exclusively with assisted reproductive
technologies.
VI. PROPOSED REGULATION
I would like to make the following regulatory proposals based
on the Warnock Committee Report. 161
162. Marketing of human reproduction has already begun in the form of sex pre-selections
kits, genetic screening devices, for-profit sperm banks and surrogacy.
163. U.S. v. Lopez, 115 S. Ct. 1624 (1995), illustrates that some limits still exist on Con-
gress's Commerce Clause powers. Congress must include explicit findings in the statute that
the activity being regulated substantially affected commerce. It is not enough that the activity
being regulated merely "affects" interstate commerce; the activity must "substantially affect"
interstate commerce. See also NLRB v. Jones & Laughlin Steel Corp., 301 U.S. 1 (1937) (the
Court substantially loosened the nexus required between the intrastate activity being regulated
and interstate commerce); Wickard v. Filbum, 317 U.S. 111 (1942) (expanded Commerce
Clause power via the cumulative effect theory. That theory provides that Congress may regu-
late not only acts which taken alone would have a substantial economic effect on interstate
commerce, but also an entire class of acts, if the class has a substantial economic effect, even
though one act within it might have virtually no interstate impact at all.).




168. BLANK, supra note 58, at 142-7. The Warnock Committee was established by the
British Parliament in July 1982. In June 25, 1984, the Committee under the direction of its
chairman Dame Mary Warnock made the influential report containing 64 separate recommen-
dations for dealing with these emerging ethical and legal issues in the new reproductive tech-
nologies. DEPT. OF HEALTH AND SOC. SEC., 98TH CONG., REPORT OF Tia WARNOCK COMMrrrEE ON
HUMAN FERTILIZATION AND EMBRYOLOGY (1984).
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SHORT TITLE
The Assisted Reproductive Technologies Act may also be cited
as ART ACT.
DEFINITIONS
The following words and phrases shall have the following
meanings in the ART ACT.
"Gamete" means the egg (ovum) and the sperm (spermatozoa).
"Person" means individual, corporation, government, agency,
business, partnership, or association or any other legal entity.
"Pre-embryo" means the cell mass that results for research in the
causes and cure of infertility.
"In-vitro" means fertilization in a glass, outside of the womb.
A. FUNDING
Sufficient federal funding shall be made available for the col-
lection of adequate statistics on infertility and infertility services.
1. Federal funds shall be used for research in the causes and
cure of infertility.
B. LICENSING COMMITTEE
To regulate the research and the infertility services, a licensing
committee shall be established.
1. The licensing committee shall include representatioi' by
laypersons and members who represent medical administra-
tion and personnel and physicians with knowledge or skill in
the field of reproductive technologies.
2. The licensing committee shall oversee any treatment or
research involving human embryos created in vitro or taken
from the womb of the mother.
3. The licensing committee shall be responsible for licens-
ing and collecting data on facilities offering reproductive
services.
4. The licensing committee shall maintain a central data
bank of all gamete and embryo donations and live births re-
sulting from these donations.
5. The licensing committee shall receive from each licensed
clinic monthly records of the type of service offered (IVF,
GIFT, ZIFT), the number of cycles attempted, the number of
live births, the number of failed attempts, and the ages of the
patients.
6. The licensing committee shall review the data as it
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evolves and publish a report each year.
7. The annual report shall contain:
a. the names of the licensed clinics;
b. the types of services offered;
c. the number of attempted cycles of IVF and other
kinds of services such as ZIFT and GIFT;
d. the number of failed attempts at IVF, ZIFT, GIFT;
and
e. the ages of the patients.
8. This annual report shall be made available to each clinic
and each potential client shall be given a copy of the annual
report prior to obtaining any reproductive services.
9. The licensing committee shall conduct follow up studies
of children born as a result of the new reproductive tech-
nologies.
C. EMBRYOS, SEMEN, EGGS
1. The sale of embryos or gametes shall not be permitted.
2. Written informed consent shall be obtained from the
couple regarding the disposition of extra embryos prior to
any reproductive treatment.
3. No research shall occur on the extra embryos without the
written informed consent of the couple who produced the
embryo.
a. No pre-embryo that has been donated for use in re-
search shall be transferred to a uterine cavity.
b. The number of embryos required for research must
be kept to the minimum.
c. The donors of gametes or embryos must have given
informed consent with regard to the nature and purpose
of the specific research being undertaken.
d. The research must only be conducted by scientifi-
cally qualified individuals in an appropriate research
setting.
4. All semen and egg deposits shall be reviewed every five
years, after which time, the right to use or dispose shall pass
to the storage clinic.
5. Gametes and pre-embryos shall not be transferable by
will or intestate succession.
6. Storage of embryos not to exceed a maximum of ten
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years.
7. All potential clients shall be told about the semen, egg,
and embryo policy regarding its disposition after the allotted
time.
8. No live human embryo derived from in vitro fertilization,
whether frozen or unfrozen, shall be kept alive, if not trans-
ferred to a woman beyond 14 days after fertilization, nor
may it be used for research beyond the 14 days after fertili-
zation.
D. PRACTITIONERS
1. The clinic and practitioners offering any reproductive
services shall be licensed by the licensing committee, in-
cluding the clinics providing for the storage of semen,
sperm, human eggs, and embryos.
2. The qualifications and experience of the clinicians on
staff at each clinic shall be reported to the licensing com-
mittee.
3. The physician shall obtain written informed consent from
the patient prior to using the sperm or ova for purposes other
than re-implantation in the same patient or implantation in
the patient's spouse.
4. Physician shall provide a copy of the patient's written
consent to any hospital in which the procedure to remove
the patient's sperm or ova is performed.
B. PATIENTS
1. Counseling shall be provided to all couples and third
parties involved in the reproductive process prior to and
throughout the treatment.
2. Each potential client shall receive accurate statistics from
the licensing committee regarding the success of the proce-
dure they undergo. (Annual report by the licensing com-
mittee)
3. Each patient shall sign a written consent to the disposi-
tion of any unused donated materials.
F. SANCTIONS
1. Use of any of the reproductive techniques without an ap-
propriate license from the licensing committee is a criminal
offense.
2. A person who acts in willful noncompliance with any
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part of the ART ACT:
a. shall be guilty of a criminal offense;
b. shall be liable for resulting damages.
3. Participating in the sale of embryos or gametes will result
in a $60,000.00 fine and an 8 year maximum prison term.
a. Utilizing the eggs or embryos from one patient and
implanting in another patient without prior written
authorization will result in loss of license and 5 year
maximum prison term and $50,000.00 fine.
4. Performing reproductive services without a license from
the licensing committee may result in $20,000 fine and 3
year maximum prison term.
5. Fraudulent actions and misrepresentations may result in
maximum 8 year prison term and $35,000.00 fine.
6. Subsequent violations may result in double penalties.
7. The sanctions provided in this section are in addition to
any other sanctions provided under applicable law.
VII.CONCLUSION
Regulation of reproductive technologies would be a solution to
the potential for egregious abuses which currently exist. The advan-
tages of federal involvement include a centralized forum for dis-
cussing reproductive techniques which would draw national attention
in a way that debates within state legislatures fail to do.169 Restrict-
ing the abuses and legislating the contexts and conditions under
which such technologies can be used would allow technological ad-
vances to be seen as progress. Such legislation should function as a
quality control measure to eliminate those IVF clinics operating be-
low federal standards. Thus, success rates could accurately be de-
termined and the risks to women and children could be managed.
As this fast-growing technology reaches new levels by providing
more advanced methods of assisting reproduction, the need to estab-
lish policies and control measures becomes urgent. The future could
provide the use of such technologies in altering or developing spe-
cific characteristics of an offspring. Resolution of the controversies
will determine how available these techniques become and their ul-
timate effects on society.
169. ANDm BoNicKsE, IN VrmO FEmTILZATION: BUILDING POLICY FROM LABoRAToRIEs TO
LEGISLATURES 95 (1989).
1997] ASSISTED REPRODUCTIVE TECHNOLOGIES 543
Some people'believe that this technological control over repro-
duction has rendered the human being "master and owner of Na-
ture." 170 That is, by manipulating Nature scientists are playing God,
thereby diminishing the mystery of conception and pregnancy.171
Implementation of a national policy would allow Congress to address
societal values which would influence the boundaries and future di-
rection of such reproductive technologies. "The technology is un-
derway, but how we as a species choose to use it, where we allow it
to be used, and when we draw limits are critical issues for all of
us .... 172
Finally, further investigation of infertility is warranted. Federal
involvement must continue at a greater level to inform state legisla-
tures and the public of the issues created by these new technologies.
The medical profession's attempt to self-regulate the new assisted re-
productive technologies must be addressed because patient exploita-
tion and abuses persist. It is the responsibility of the federal govern-
ment to examine and to regulate in vitro fertilization to protect
consumers.
170. KURT BAYERTZ, GaEEnmics, TECHNOLOGICAL INTERVENTION IN HUMAN REPRODUCTION AS A
PHILOSOPHICAL PROBLEM 173 (1994).
171. ROBERTSON, supra note 43, at 12-15.
172. B.AwK & MERRICK, supra note 1, at 225.

